- Home
- PZZA vs VERA Comparison
PZZA vs VERA Comparison
Compare PZZA & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PZZA
- VERA
- Stock Information
- Founded
- PZZA 1984
- VERA 2016
- Country
- PZZA United States
- VERA United States
- Employees
- PZZA N/A
- VERA N/A
- Industry
- PZZA Restaurants
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- PZZA Consumer Discretionary
- VERA Health Care
- Exchange
- PZZA Nasdaq
- VERA Nasdaq
- Market Cap
- PZZA 1.5B
- VERA 1.7B
- IPO Year
- PZZA 1993
- VERA 2021
- Fundamental
- Price
- PZZA $44.78
- VERA $31.07
- Analyst Decision
- PZZA Buy
- VERA Buy
- Analyst Count
- PZZA 10
- VERA 8
- Target Price
- PZZA $50.00
- VERA $64.29
- AVG Volume (30 Days)
- PZZA 913.5K
- VERA 1.5M
- Earning Date
- PZZA 11-06-2025
- VERA 11-06-2025
- Dividend Yield
- PZZA 4.13%
- VERA N/A
- EPS Growth
- PZZA 8.47
- VERA N/A
- EPS
- PZZA 2.28
- VERA N/A
- Revenue
- PZZA $2,085,052,000.00
- VERA N/A
- Revenue This Year
- PZZA $4.55
- VERA N/A
- Revenue Next Year
- PZZA $0.93
- VERA N/A
- P/E Ratio
- PZZA $19.55
- VERA N/A
- Revenue Growth
- PZZA N/A
- VERA N/A
- 52 Week Low
- PZZA $30.16
- VERA $18.53
- 52 Week High
- PZZA $60.75
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- PZZA 41.30
- VERA 79.29
- Support Level
- PZZA $44.84
- VERA $28.48
- Resistance Level
- PZZA $49.01
- VERA $29.97
- Average True Range (ATR)
- PZZA 1.51
- VERA 1.39
- MACD
- PZZA -0.22
- VERA 0.38
- Stochastic Oscillator
- PZZA 4.56
- VERA 92.90
About PZZA Papa John's International Inc.
Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.